Back to search

The University of Edinburgh

Multi omics-analysis and compounds supplementation identifies B. subtilis produced metabolites that reduce α-synuclein aggregation in C. elegans

Abstract

dc:description.abstract

The aggregation of α-synuclein is a pathological hallmark of Parkinson’s disease. In this study, we used the nematode Caenorhabditis elegans as a model to investigate the potential mechanisms via which the bacterium Bacillus subtilis protects against α-synuclein aggregation. Previous findings from our lab showed that feeding C. elegans with B. subtilis significantly reduces α-synuclein aggregation compared to the standard laboratory diet Escherichia coli OP50. A genetic screen in B. subtilis revealed that deletion of specific genes involved in central metabolism pathways abolished this protective effect, suggesting that bacterial compounds produced by these pathways play a key role in modulating aggregation. This study aimed to identify the metabolites responsible for this protective effect, assess whether their activity requires metabolically active bacteria, and clarify the mechanism underlying the protective effects of B. subtilis on host. I integrated metabolomics and transcriptomics to identify candidate metabolites that were significantly downregulated in non-protective mutants, then tested their ability to rescue the aggregation phenotype by supplementing them into worm growth media. To determine whether live bacteria were necessary for protection, supplementation assays were also conducted with inactivated B. subtilis. In parallel, proteomic analysis was performed to examine host molecular responses. Combination of transcriptomics and metabolomics identified 33 downregulated metabolites as candidates, many of which are linked to the branched-chain amino acid and bacilysocin biosynthesis pathway. Supplementation with selected metabolites including 12-methyltetradecanoic acid, 2-oxobutyric acid, AMP, asparagine, and fumarate significantly rescued aggregation phenotypes. The protective effect of some metabolites, such as 12-methyltetradecanoic acid and 2-oxobutyric acid, was independent of bacterial activity, suggesting a direct action on the host. Proteomics revealed that protective strains primarily promote host proteolysis and strengthen cellular barriers to facilitate aggregate clearance. In conclusion, this study identifies B. subtilis metabolites that mediate the protective effect and elucidates their mechanism of action. These findings contribute to a deeper understanding of gut microbe–host interactions in neurodegenerative disease.

Degree

thesis:*
Grantor dc:publisher
The University of Edinburgh
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Guan, Jiaxi
Advisors dc:contributor.advisor
  • Doitsidou, Maria
  • Prakash, Deep

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Guan, Jiaxi. Multi omics-analysis and compounds supplementation identifies B. subtilis produced metabolites that reduce α-synuclein aggregation in C. elegans. The University of Edinburgh, 2025. https://hdl.handle.net/1842/44256